Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Taysha Gene Therapies ( (TSHA)) just ...

I don’t use Microsoft Excel all that often, so it remains a bit of a mystery to me. I can enter text and create graphs and that’s basically it. That’s why I’ve set myself a goal to learn one new Excel ...

State-of-the-art single-cell RNA sequencing and proteomics approaches were employed to benchmark porcine and human pancreatic ...

Regeneron has posted updated clinical data on DB-OTO, providing more evidence of the gene therapy’s potential to treat a rare genetic form of deafness as it plans for a potential FDA filing later this ...

Regeneron Pharmaceuticals, Inc. REGN announced updated data on its investigational gene therapy DB-OTO from the CHORD study. This gene therapy is being evaluated for profound genetic hearing loss due ...

Apple analysts and investors are continuing to track lead times on the new iPhone 17, which could point to how demand there is for the company's latest smartphone. "Since launch, the global lead time ...

In early October 2025, Intellia Therapeutics presented new clinical results at the European Society of Gene & Cell Therapy Congress, highlighting long-term safety and efficacy data for its ...

The Cancer Gene Census (CGC) is a widely used module within the Catalogue Of Somatic Mutations In Cancer (COSMIC) that comprises an ongoing effort to catalogue and describe all genes with causal ...

Moderna has shared some of the phase 1/2 data that persuaded it to expand and prioritize development of a cancer candidate, reporting responses in melanoma patients failed by checkpoint inhibitors.